vs
Organogenesis Holdings Inc.(ORGO)与Pioneer Bancorp, Inc.(PBFS)财务数据对比。点击上方公司名可切换其他公司
Organogenesis Holdings Inc.的季度营收约是Pioneer Bancorp, Inc.的1.5倍($37.2M vs $25.0M),过去两年Pioneer Bancorp, Inc.的营收复合增速更高(144.9% vs -46.5%)
Organogenesis Holdings Inc.是一家领先的再生医学企业,专注于开发、生产用于伤口护理、外科修复、运动医学和皮肤病领域的先进治疗产品,主要服务美国及部分国际市场的医疗机构与患者,提供经临床验证的医疗解决方案。
先锋银行控股公司(马里兰州)是一家美国银行控股企业,为先锋银行的母公司,主要面向马里兰州本地社区用户提供零售及商业银行服务,涵盖存款账户、住房与商业抵押贷款、消费贷款及小微企业融资等产品。
ORGO vs PBFS — 直观对比
营收规模更大
ORGO
是对方的1.5倍
$25.0M
两年增速更快
PBFS
近两年复合增速
-46.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $37.2M | $25.0M |
| 净利润 | — | $3.7M |
| 毛利率 | 30.8% | — |
| 营业利润率 | -185.1% | 21.3% |
| 净利率 | — | 82.1% |
| 营收同比 | -57.1% | — |
| 净利润同比 | — | — |
| 每股收益(稀释后) | — | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ORGO
PBFS
| Q1 26 | $37.2M | — | ||
| Q4 25 | $225.6M | $25.0M | ||
| Q3 25 | $150.9M | $24.0M | ||
| Q2 25 | $101.0M | $24.4M | ||
| Q1 25 | $86.7M | $22.8M | ||
| Q4 24 | $126.7M | — | ||
| Q3 24 | $115.2M | $22.0M | ||
| Q2 24 | $130.2M | $20.9M |
净利润
ORGO
PBFS
| Q1 26 | — | — | ||
| Q4 25 | $43.7M | $3.7M | ||
| Q3 25 | $21.6M | $4.3M | ||
| Q2 25 | $-9.4M | $6.5M | ||
| Q1 25 | $-18.8M | $5.8M | ||
| Q4 24 | $7.7M | — | ||
| Q3 24 | $12.3M | $6.3M | ||
| Q2 24 | $-17.0M | $3.9M |
毛利率
ORGO
PBFS
| Q1 26 | 30.8% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 72.6% | — | ||
| Q4 24 | 75.5% | — | ||
| Q3 24 | 76.7% | — | ||
| Q2 24 | 77.6% | — |
营业利润率
ORGO
PBFS
| Q1 26 | -185.1% | — | ||
| Q4 25 | 28.1% | 21.3% | ||
| Q3 25 | 13.7% | 23.4% | ||
| Q2 25 | -12.5% | 33.3% | ||
| Q1 25 | -30.9% | 32.5% | ||
| Q4 24 | 8.1% | — | ||
| Q3 24 | 5.4% | 37.2% | ||
| Q2 24 | -10.7% | 24.1% |
净利率
ORGO
PBFS
| Q1 26 | — | — | ||
| Q4 25 | 19.4% | 82.1% | ||
| Q3 25 | 14.3% | 18.0% | ||
| Q2 25 | -9.3% | 26.4% | ||
| Q1 25 | -21.7% | 25.3% | ||
| Q4 24 | 6.1% | — | ||
| Q3 24 | 10.7% | 28.7% | ||
| Q2 24 | -13.1% | 107.4% |
每股收益(稀释后)
ORGO
PBFS
| Q1 26 | — | — | ||
| Q4 25 | $0.31 | $0.16 | ||
| Q3 25 | $0.11 | $0.18 | ||
| Q2 25 | $-0.10 | $0.26 | ||
| Q1 25 | $-0.17 | $0.23 | ||
| Q4 24 | $0.05 | — | ||
| Q3 24 | $0.09 | $0.25 | ||
| Q2 24 | $-0.13 | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $91.4M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $323.9M |
| 总资产 | $520.0M | $2.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
ORGO
PBFS
| Q1 26 | $91.4M | — | ||
| Q4 25 | $93.7M | — | ||
| Q3 25 | $63.7M | — | ||
| Q2 25 | $73.1M | — | ||
| Q1 25 | $110.0M | — | ||
| Q4 24 | $135.6M | — | ||
| Q3 24 | $94.3M | — | ||
| Q2 24 | $89.9M | — |
总债务
ORGO
PBFS
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $62.3M | — | ||
| Q2 24 | $63.8M | — |
股东权益
ORGO
PBFS
| Q1 26 | — | — | ||
| Q4 25 | $300.1M | $323.9M | ||
| Q3 25 | $255.1M | $314.2M | ||
| Q2 25 | $233.2M | $314.2M | ||
| Q1 25 | $242.9M | $310.7M | ||
| Q4 24 | $262.9M | — | ||
| Q3 24 | $278.5M | $303.8M | ||
| Q2 24 | $263.5M | $296.5M |
总资产
ORGO
PBFS
| Q1 26 | $520.0M | — | ||
| Q4 25 | $598.7M | $2.2B | ||
| Q3 25 | $509.8M | $2.2B | ||
| Q2 25 | $461.1M | $2.1B | ||
| Q1 25 | $467.4M | $2.1B | ||
| Q4 24 | $497.9M | — | ||
| Q3 24 | $446.3M | $2.0B | ||
| Q2 24 | $443.2M | — |
负债/权益比
ORGO
PBFS
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.22× | — | ||
| Q2 24 | 0.24× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $11.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 2.97× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
ORGO
PBFS
| Q1 26 | — | — | ||
| Q4 25 | $39.4M | $11.1M | ||
| Q3 25 | $3.1M | $3.9M | ||
| Q2 25 | $-32.9M | $5.1M | ||
| Q1 25 | $-19.9M | $-3.5M | ||
| Q4 24 | $10.9M | — | ||
| Q3 24 | $8.7M | $1.9M | ||
| Q2 24 | $4.7M | $9.0M |
自由现金流
ORGO
PBFS
| Q1 26 | — | — | ||
| Q4 25 | $34.8M | — | ||
| Q3 25 | $844.0K | — | ||
| Q2 25 | $-36.5M | — | ||
| Q1 25 | $-23.6M | — | ||
| Q4 24 | $7.6M | — | ||
| Q3 24 | $6.1M | — | ||
| Q2 24 | $2.9M | — |
自由现金流率
ORGO
PBFS
| Q1 26 | — | — | ||
| Q4 25 | 15.4% | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | -36.1% | — | ||
| Q1 25 | -27.2% | — | ||
| Q4 24 | 6.0% | — | ||
| Q3 24 | 5.3% | — | ||
| Q2 24 | 2.2% | — |
资本支出强度
ORGO
PBFS
| Q1 26 | — | — | ||
| Q4 25 | 2.1% | — | ||
| Q3 25 | 1.5% | — | ||
| Q2 25 | 3.6% | — | ||
| Q1 25 | 4.2% | — | ||
| Q4 24 | 2.7% | — | ||
| Q3 24 | 2.2% | — | ||
| Q2 24 | 1.4% | — |
现金转化率
ORGO
PBFS
| Q1 26 | — | — | ||
| Q4 25 | 0.90× | 2.97× | ||
| Q3 25 | 0.14× | 0.90× | ||
| Q2 25 | — | 0.78× | ||
| Q1 25 | — | -0.61× | ||
| Q4 24 | 1.43× | — | ||
| Q3 24 | 0.71× | 0.30× | ||
| Q2 24 | — | 2.30× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图